The window of implantation is defined by the inhibition of uterine epithelial proliferation, structural epithelial cell remodeling, and attenuated estrogen (E2) response. These changes occur via paracrine signaling between the uterine epithelium and stroma. Because implantation defects are a major cause of infertility in women, identifying these signaling pathways will improve infertility interventions. Bone morphogenetic proteins (BMPs) are TGF-β family members that regulate the postimplantation and midgestation stages of pregnancy. In this study, we discovered that signaling via activin-like kinase 3 (ALK3/BMPR1A), a BMP type 1 receptor, is necessary for blastocyst attachment. Conditional knockout (cKO) of ALK3 in the uterus was obtained by producing Alk3 flox/flox -Pgr-cre-positive females. Alk3 cKO mice are sterile and have defects in the luminal uterine epithelium, including increased microvilli density and maintenance of apical cell polarity. Moreover, Alk3 cKO mice exhibit an elevated uterine E2 response and unopposed epithelial cell proliferation during the window of implantation. We determined that dual transcriptional regulation of Kruppel-like factor 15 (Klf15), by both the transforming growth factor β (TGF-β) transcription factor SMAD family member 4 (SMAD4) and progesterone receptor (PR), is necessary to inhibit uterine epithelial cell proliferation, a key step for embryo implantation. Our findings present a convergence of BMP and steroid hormone signaling pathways in the regulation of uterine receptivity.BMP signaling pathway | endometrium | implantation failure | infertility | progesterone receptor D rastic structural and molecular changes are necessary for the luminal uterine epithelium to achieve a receptive status. Because it is the first site of contact between the mother and the invading blastocyst, remodeling of the luminal epithelium is crucial for establishing a successful pregnancy (1, 2). The steroid hormones, estrogen (E2) and progesterone (P4), coordinate many of these changes; however, many other growth factors and cytokines are involved (3, 4). The bone morphogenetic proteins (BMPs) are a class of growth factors that are important during pregnancy. BMPs are members of the transforming growth factor β (TGF-β) signaling pathway that regulate many cellular pathways, including processes related to normal reproductive function and pregnancy (5-13). BMPs transmit their signals by binding to a cell surface heterodimeric receptor complex that is composed of a combination of two type 1 receptors [activin-like kinase 2 (ALK2), ALK3, or ALK6] and two type 2 receptors [activin A receptor type II A (ACVR2A), ACVR2B, or BMP type 2 receptor (BMPR2)] (14-16). Upon ligand binding, the heterodimeric BMP receptor complex signals by phosphorylating and activating SMAD1/5/8, which associate with SMAD family member 4 (SMAD4) and translocate to the nucleus to regulate gene expression (17).BMPs are expressed in a temporal manner throughout early and late pregnancy (18), and conditional deletion of BMP2 resu...